These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30758866)

  • 1. Biologic-induced urticaria due to polysorbate 20.
    Kato M; Oiso N; Uchida S; Yanagihara S; Sano H; Tohda Y; Kawada A
    J Dermatol; 2019 Jul; 46(7):e230-e232. PubMed ID: 30758866
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic-induced urticaria due to polysorbate 80: usefulness of prick test.
    Pérez-Pérez L; García-Gavín J; Piñeiro B; Zulaica A
    Br J Dermatol; 2011 May; 164(5):1119-20. PubMed ID: 21219296
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of severe immediate type reaction to macrogol and polysorbate 60 after intravaginal drug application.
    Schwede K; Simon JC; Treudler R
    Eur J Dermatol; 2019 Jun; 29(3):329-331. PubMed ID: 31389792
    [No Abstract]   [Full Text] [Related]  

  • 4. An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity.
    Limaye S; Steele RH; Quin J; Cleland B
    J Allergy Clin Immunol; 2002 Sep; 110(3):530. PubMed ID: 12209107
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
    Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
    Drug Dev Ind Pharm; 2016 Apr; 42(4):676-684. PubMed ID: 26266963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.
    Perino E; Freymond N; Devouassoux G; Nicolas JF; Berard F
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):664-666. PubMed ID: 29481891
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80.
    Badiu I; Geuna M; Heffler E; Rolla G
    BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22605841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact urticaria to a corticosteroid cream: polysorbate 60.
    Maibach H; Conant M
    Contact Dermatitis; 1977 Dec; 3(6):350-1. PubMed ID: 606492
    [No Abstract]   [Full Text] [Related]  

  • 9. Furacin: More than just contact dermatitis from nitrofurazone.
    Cuevas Bravo C; Crespo Quirós J; Noguerado Mellado B; Rojas Pérez-Ezquerra P
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):389-390. PubMed ID: 34087479
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaphylaxis Due to the Excipient Polysorbate 80.
    Palacios Castaño MI; Venturini Díaz M; Lobera Labairu T; González Mahave I; Del Pozo Gil MD; Blasco Sarramián A
    J Investig Allergol Clin Immunol; 2016; 26(6):394-396. PubMed ID: 27996954
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin.
    Steele RH; Limaye S; Cleland B; Chow J; Suranyi MG
    Nephrology (Carlton); 2005 Jun; 10(3):317-20. PubMed ID: 15958049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Injection Site Reactions in Monoclonal Antibody Therapies Caused by Polysorbate Excipient Degradants?
    Singh SK; Mahler HC; Hartman C; Stark CA
    J Pharm Sci; 2018 Nov; 107(11):2735-2741. PubMed ID: 30055223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80].
    Pantín C; Letellez J; Calzas J; Mohedano E
    Farm Hosp; 2018 Jan; 42(1):27-28. PubMed ID: 29306312
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro testing of tensides employing monolayer cultures: a comparison with results of patch tests on human volunteers.
    Benassi L; Bertazzoni G; Seidenari S
    Contact Dermatitis; 1999 Jan; 40(1):38-44. PubMed ID: 9928803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 hypersensitivity reaction to carboxymethylcellulose following intra-articular triamcinolone injection.
    Field S; Falvey E; Barry J; Bourke J
    Contact Dermatitis; 2009 Nov; 61(5):302-3. PubMed ID: 19878250
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y; Wilson L
    PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Omalizumab with Another Biotherapy.
    Fougerousse AC; Becherel PA; Pallure V; Boyé T; Reguiai Z; Gabison G; Barthelemy H; Badaoui A; Mahé E; Livideanu CB;
    Acta Derm Venereol; 2019 Apr; 99(4):448-449. PubMed ID: 30723874
    [No Abstract]   [Full Text] [Related]  

  • 18. Considerations for the Use of Polysorbates in Biopharmaceuticals.
    Jones MT; Mahler HC; Yadav S; Bindra D; Corvari V; Fesinmeyer RM; Gupta K; Harmon AM; Hinds KD; Koulov A; Liu W; Maloney K; Wang J; Yeh PY; Singh SK
    Pharm Res; 2018 May; 35(8):148. PubMed ID: 29797101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin sensitivity: acetylsalicylate or excipients.
    Hebron BS; Hebron HJ
    Intern Med J; 2009 Aug; 39(8):546-9. PubMed ID: 19732201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral nutrition hypersensitivity.
    Levy M; Dupuis LL
    JPEN J Parenter Enteral Nutr; 1990; 14(2):213-5. PubMed ID: 2112631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.